Clinical Trial Update: Safety and Efficacy of YHD1023 in Erectile Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the safety and efficacy of YHD1023 for erectile dysfunction has been completed. The study was sponsored by Yuhan Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• YHD1023

Snippet

Sponsor: Yuhan Corporation | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED